186 related articles for article (PubMed ID: 11882463)
1. Characterization of bone mineral composition in the proximal tibia of cynomolgus monkeys: effect of ovariectomy and nandrolone decanoate treatment.
Huang RY; Miller LM; Carlson CS; Chance MR
Bone; 2002 Mar; 30(3):492-7. PubMed ID: 11882463
[TBL] [Abstract][Full Text] [Related]
2. A physical, chemical, and mechanical study of lumbar vertebrae from normal, ovariectomized, and nandrolone decanoate-treated cynomolgus monkeys (Macaca fascicularis).
Gadeleta SJ; Boskey AL; Paschalis E; Carlson C; Menschik F; Baldini T; Peterson M; Rimnac CM
Bone; 2000 Oct; 27(4):541-50. PubMed ID: 11033450
[TBL] [Abstract][Full Text] [Related]
3. The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys.
Jerome CP; Power RA; Obasanjo IO; Register TC; Guidry M; Carlson CS; Weaver DS
Bone; 1997 Apr; 20(4):355-64. PubMed ID: 9108356
[TBL] [Abstract][Full Text] [Related]
4. The effects of nandrolone decanoate on bone mass and metabolism in ovariectomized rats with osteopenia.
Li X; Takahashi M; Kushida K; Shimizu S; Hoshino H; Suzuki M; Inoue T
J Bone Miner Metab; 2000; 18(5):258-63. PubMed ID: 10959614
[TBL] [Abstract][Full Text] [Related]
5. Mechanical properties, bone mineral content, and bone composition (collagen, osteocalcin, IGF-I) of the rat femur: influence of ovariectomy and nandrolone decanoate (anabolic steroid) treatment.
Aerssens J; Van Audekercke R; Geusens P; Schot LP; Osman AA; Dequeker J
Calcif Tissue Int; 1993 Oct; 53(4):269-77. PubMed ID: 8275356
[TBL] [Abstract][Full Text] [Related]
6. Nandrolone decanoate causes pathologic changes in the uterus of surgically postmenopausal female cynomolgus macaques.
Obasanjo IO; Cline JM; Schmotzer S; Weaver DS
Menopause; 1998; 5(3):163-8. PubMed ID: 9774762
[TBL] [Abstract][Full Text] [Related]
7. Effects of the anabolic steroid nandrolone decanoate on plasma lipids and coronary arteries of female cynomolgus macaques.
Obasanjo IO; Clarkson TB; Weaver DS
Metabolism; 1996 Apr; 45(4):463-8. PubMed ID: 8609832
[TBL] [Abstract][Full Text] [Related]
8. Behavioral responses to ovariectomy and chronic anabolic steroid treatment in female cynomolgus macaques.
Stavisky RC; Register TC; Watson SL; Weaver DS; Kaplan JR
Physiol Behav; 1999 Mar; 66(1):95-100. PubMed ID: 10222479
[TBL] [Abstract][Full Text] [Related]
9. In situ chemistry of osteoporosis revealed by synchrotron infrared microspectroscopy.
Huang RY; Miller LM; Carlson CS; Chance MR
Bone; 2003 Oct; 33(4):514-21. PubMed ID: 14555254
[TBL] [Abstract][Full Text] [Related]
10. Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis.
Flicker L; Hopper JL; Larkins RG; Lichtenstein M; Buirski G; Wark JD
Osteoporos Int; 1997; 7(1):29-35. PubMed ID: 9102059
[TBL] [Abstract][Full Text] [Related]
11. Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?
Johansen JS; Hassager C; Pødenphant J; Riis BJ; Hartwell D; Thomsen K; Christiansen C
Bone Miner; 1989 Apr; 6(1):77-86. PubMed ID: 2665884
[TBL] [Abstract][Full Text] [Related]
12. Nandrolone decanoate for men with osteoporosis.
Hamdy RC; Moore SW; Whalen KE; Landy C
Am J Ther; 1998 Mar; 5(2):89-95. PubMed ID: 10099043
[TBL] [Abstract][Full Text] [Related]
13. Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys.
Yamada H; Ochi Y; Mori H; Nishikawa S; Hashimoto Y; Nakanishi Y; Tanaka M; Bruce M; Deacon S; Kawabata K
Bone; 2016 May; 86():43-52. PubMed ID: 26921823
[TBL] [Abstract][Full Text] [Related]
14. Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.
Gennari C; AgnusDei D; Gonnelli S; Nardi P
Maturitas; 1989 Sep; 11(3):187-97. PubMed ID: 2687645
[TBL] [Abstract][Full Text] [Related]
15. Calcium-deficient diet in ovariectomized dogs limits the effects of 17 beta-estradiol and nandrolone decanoate on bone.
Geusens P; Schot LP; Nijs J; Dequeker J
J Bone Miner Res; 1991 Aug; 6(8):791-7. PubMed ID: 1785371
[TBL] [Abstract][Full Text] [Related]
16. Double-blind placebo--controlled trial of nandrolone decanoate in postmenopausal osteoporosis.
Chhaparwal M; Saraf ML
Indian J Med Sci; 1998 Jun; 52(6):236-8. PubMed ID: 9849033
[No Abstract] [Full Text] [Related]
17. [Effects on the bones of nandrolone decanoate therapy in postmenopausal osteoporosis].
Gennari C; Agnusdei D; Gonnelli S
Minerva Endocrinol; 1989; 14(1):69-74. PubMed ID: 2659955
[TBL] [Abstract][Full Text] [Related]
18. Bodybuilders' body composition: effect of nandrolone decanoate.
van Marken Lichtenbelt WD; Hartgens F; Vollaard NB; Ebbing S; Kuipers H
Med Sci Sports Exerc; 2004 Mar; 36(3):484-9. PubMed ID: 15076791
[TBL] [Abstract][Full Text] [Related]
19. Nandrolone decanoate induces cardiac and renal remodeling in female rats, without modification in physiological parameters: The role of ANP system.
Brasil GA; Lima EM; Nascimento AM; Caliman IF; Medeiros AR; Silva MS; Abreu GR; Reis AM; Andrade TU; Bissoli NS
Life Sci; 2015 Sep; 137():65-73. PubMed ID: 26165753
[TBL] [Abstract][Full Text] [Related]
20. Effects of nandrolone decanoate on bone mass in established osteoporosis.
Passeri M; Pedrazzoni M; Pioli G; Butturini L; Ruys AH; Cortenraad MG
Maturitas; 1993 Nov; 17(3):211-9. PubMed ID: 8133796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
